RD-ET-RDA-26-001: Improving The Capacity of Tribal Communities to Identify Emerging Drug Threats
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Office of National Drug Control Policy notices from 2026.
Office of National Drug Control Policy offered grants of up to $300,000 to nonprofits, colleges and universities and tribes. It expected to make one award. Applications closed on August 31, 2026.
From the official notice on Grants.gov, last changed August 14, 2026. Checked November 7, 2026.
- Award ceiling$300,000
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| RD-ET-RDA-26-002 | September 2, 2026 | Closed September 13, 2026 | Closed |
Key dates
| Posted | August 14, 2026 |
|---|---|
| Deadline | August 31, 2026 |
| Archived by Grants.gov | September 30, 2026 |
Who can apply
This opportunity was open to nonprofits, colleges and universities and tribes.
All 6 applicant types the notice lists
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Hospitals
Is this a realistic fit?
- Past Research and Data Analysis awards averaged $915,665; this notice allows up to $300,000 per award.
- Most of the program's money (65% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
This project would fund researchers to address key impediments or challenges that Tribal communities face related to their capacity to identify emerging drug threats and conduct a pilot project to help these communities improve their capacity to detect and respond to emerging drug threats.
Who has won Research and Data Analysis grants before
From fiscal 2021 to 2025, Research and Data Analysis (95.007) awarded $9.2 million across 10 grant awards, an average of $915,665 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| University of Baltimore | Maryland | 2 | $5.9 million |
| National Association of County and City Health Officials | District of Columbia | 1 | $1.2 million |
| National Foundation for the Centers for Disease Control & Prevention, Inc. | Georgia | 1 | $700,000 |
| University of Maryland, College Park | Maryland | 3 | $574,998 |
| American College of Medical Toxicology, Inc. | Arizona | 1 | $400,000 |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RD-ET-RDA-26-001 still open?
No. It closed on August 31, 2026.
Who can apply for Improving The Capacity of Tribal Communities to Identify Emerging Drug Threats?
Office of National Drug Control Policy accepted applications from nonprofits, colleges and universities and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Improving The Capacity of Tribal Communities to Identify Emerging Drug Threats?
Closed August 31, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $300,000 each.
Who has won Research and Data Analysis grants before?
The largest recipients over five fiscal years were University of Baltimore, National Association of County and City Health Officials, National Foundation for the Centers for Disease Control & Prevention, Inc. The program made 10 awards worth $9.2 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)